1. MARKETS
  2. SECTOR : HEALTHCARE
  3. INDUSTRY : HEALTHCARE FACILITIES
  4. PARAS HEALTHCARE LTD.
Paras Healthcare Ltd.
NSE: PARASHLTH | BSE: 545005|ASM

Paras Healthcare Live Share Price Today, Share Analysis and Chart

aboutParas Healthcare was incorporated on December 21, 1987. It is the fifth largest healthcare provider in terms of bed capacity in North India, Bihar, and Jharkhand. The company has eight hospitals that operate under the “Paras Health” brand, which are ... Read More
Ask AI about Paras Healthcare
834.955.15(0.62%)
323.7K
NSE+BSE Volume

NSE 19 Nov, 2026 3:31 PM

Portfolio

Alert

My Notes

Paras Healthcare Stock Price Ranges

Paras Healthcare Technical Analysis

Paras Healthcare EMA & SMA

Bullish+1
Bullish2
Bearish1
5 Day850.0
10 Day834.7
12 Day822.5

Paras Healthcare Delivery And Volume

Daily Avg. Delivery Volume %
19 Nov, 202632.0%
Week24.5%
Month37.3%

Paras Healthcare Active Candlesticks

Spinning Top Uptrend
PositiveNeutralNegative

Paras Healthcare Resistance and Support

831.25
Pivot
First Resistance851.3
Second Resistance867.7
Third Resistance887.7
First Support814.9
Second Support794.9
Third Support778.5
Day RSI59.9
Day MACD-
Day MFI78.2
Day MACD Signal Line-

Paras Healthcare Beta

1 Month-
1 Year-
3 Month-
3 Year-

Paras Healthcare Price Change Analysis

↑20.5%
Over 1 Month
LowHigh
706949
↑20.5%
Over 3 Months
LowHigh
706949
↑20.5%
Over 6 Months
LowHigh
706949
↑20.5%
Over 1 Year
LowHigh
706949

Paras Healthcare Shareholding Pattern/ Ownership

Shareholding Summary

 
NameCategorySharesShares %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Paras Healthcare Corporate Actions

Paras Healthcare Board Meetings

Paras Healthcare past and upcoming board meetings.

#Ex-Date
PurposeNotes
105 Nov 2026
Quarterly Results-

Paras Healthcare Research Reports

Paras Healthcare research reports with share price targets, and buy/hold/sell recommendations from top brokers.

#
Date
Broker NameTargetPrice When RecommendedTypeUpsideChange Since RecommendationLinks
120 Oct 2026Deven Choksey--IPO Subscribe--%pdf
218 Oct 2026ICICI Direct--IPO Note--%pdf
318 Oct 2026Ventura--IPO Subscribe--%pdf

Paras Healthcare Corporate Filings

Paras Healthcare BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

DateAnnouncement TitleDetailsLinks
13 Nov 2026
Paras Healthcare Ltd - 545005 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the Earnings Conference Call held to discuss the Financial Results of the Company for the Quarter and half year ended September 30, 2026
PDF
12 Nov 2026
Paras Healthcare Ltd - 545005 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor Meet under Regulation 30 of SEBI Listing Regulations
PDF
06 Nov 2026
Paras Healthcare Ltd - 545005 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recording of Earnings Call on Financial Results of the Company for the Quarter and Half Year ended September 30, 2026
PDF
06 Nov 2026
Paras Healthcare Results Earnings Call for Q2FY27
Conference Call with Paras Healthcare Management and Analysts on Q2FY27 Performance and Outlook. Listen to the full earnings transcript.
PDF
06 Nov 2026
Q2FY27 Quarterly Result Announced for Paras Healthcare Ltd.
Healthcare Facilities company Paras Healthcare announced Q2FY27 results Standalone Financial Highlights: Revenue from operations: Standalone revenue from operations for Q2FY27 stood at Rs 4,129.71 million, representing a sequential increase of 6.82% QoQ from Rs 3,866.17 million in Q1FY27 and an expansion of 15.63% YoY from Rs 3,571.34 million in Q2FY26. For H1FY27, standalone revenue reached Rs 7,995.88 million, up 17.50% YoY from Rs 6,804.96 million in H1FY26. Total income: Standalone total income for Q2FY27 was Rs 4,274.23 million, up 6.15% QoQ compared to Rs 4,026.52 million in Q1FY27 and up 15.63% YoY against Rs 3,696.36 million in Q2FY26. For H1FY27, standalone total income totalled Rs 8,300.75 million, marking a 17.83% YoY increase over Rs 7,044.86 million in H1FY26. Profit before tax (PBT): Standalone PBT for Q2FY27 came in at Rs 527.19 million, rising 6.96% QoQ from Rs 492.90 million in Q1FY27 and increasing 67.59% YoY over Rs 314.58 million in Q2FY26. For H1FY27, standalone PBT stood at Rs 1,020.09 million, expanding 80.59% YoY from Rs 564.88 million in H1FY26. Profit after tax (PAT): Standalone PAT for Q2FY27 stood at Rs 391.76 million, gaining 6.63% QoQ relative to Rs 367.41 million in Q1FY27 and climbing 65.15% YoY against Rs 237.22 million in Q2FY26. For H1FY27, standalone PAT grew to Rs 759.17 million, showing a 79.95% YoY growth relative to Rs 421.87 million in H1FY26. Earnings per equity share (EPS): Standalone basic EPS for Q2FY27 arrived at Rs 3.88 per share, climbing 6.59% QoQ from Rs 3.64 in Q1FY27 and up 65.11% YoY from Rs 2.35 in Q2FY26. For H1FY27, standalone basic EPS stood at Rs 7.52, shifting upwards by 80.00% YoY over Rs 4.18 in H1FY26. Consolidated Financial Highlights: Revenue from operations: Consolidated revenue from operations for Q2FY27 was Rs 5,108.95 million, climbing 8.64% QoQ from Rs 4,702.78 million in Q1FY27 and expanding 22.77% YoY over Rs 4,161.25 million in Q2FY26. For H1FY27, consolidated revenue from operations aggregated to Rs 9,811.73 million, a 25.07% YoY expansion from Rs 7,845.12 million in H1FY26. Total income: Consolidated total income stood at Rs 5,173.47 million for Q2FY27, reflecting a sequential growth of 8.06% QoQ from Rs 4,787.46 million in Q1FY27 and a 22.23% YoY growth compared to Rs 4,232.38 million in Q2FY26. For H1FY27, consolidated total income touched Rs 9,960.93 million, up 24.91% YoY compared to Rs 7,974.70 million in H1FY26. Profit before tax (PBT): For Q2FY27, consolidated PBT grew to Rs 542.19 million, moving up 12.67% QoQ from Rs 481.20 million in Q1FY27 and increasing by 173.52% YoY relative to Rs 198.23 million in Q2FY26. For H1FY27, consolidated PBT reached Rs 1,023.39 million, a 298.73% YoY rise relative to Rs 256.66 million in H1FY26. Profit after tax (PAT): Consolidated PAT for Q2FY27 came in at Rs 403.50 million, dipping 18.78% QoQ against Rs 496.82 million in Q1FY27 but increasing by 225.69% YoY over Rs 123.89 million in Q2FY26. For H1FY27, consolidated PAT reached Rs 900.32 million, showing a 692.19% YoY advance over Rs 113.65 million in H1FY26. Earnings per equity share (EPS): Consolidated basic EPS for Q2FY27 stood at Rs 4.00, down 18.70% QoQ against Rs 4.92 in Q1FY27, but growing by 225.20% YoY relative to Rs 1.23 in Q2FY26. For H1FY27, consolidated basic EPS stood at Rs 8.92, increasing by 689.38% YoY compared to Rs 1.13 in H1FY26. Dharminder Kumar Nagar, Managing Director, Paras Healthcare, said: "This quarter marks an important milestone for Paras Health as we report our first results as a listed company. We are pleased to deliver a robust performance, with the quarter's revenue growing 22.8% YoY to Rs. 510.9 crore and PAT rising 3.6 times. Revenue for H1 FY27 at Rs 981 cr grew 25% YoY. Our newer hospitals at Srinagar and Kanpur have ramped up rapidly and turned strongly EBITDA positive, while our mature hospitals continue to deliver industry-leading margins. Out of the IPO proceeds of Rs 500 crore, we deployed Rs 375 crore towards part repayment of our borrowings, making our balance sheet significantly stronger. We will continue to deepen our specialty programmes, including oncology, cardiac, neuro and renal sciences, invest in advanced clinical technology and expand our presence in the underserved markets of North India." Result PDF
PDF

Paras Healthcare Documents

Paras Healthcare Earnings Call

Paras Healthcare earnings calls, including management commentary and AI-generated summaries.

DateTitleLinks
13 Nov 2026Paras Healthcare Ltd - 545005 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
06 Nov 2026Paras Healthcare Ltd - 545005 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
06 Nov 2026Paras Healthcare Results Earnings Call for Q2FY27

Paras Healthcare Investor Presentations

Paras Healthcare investor presentations, including business updates, financial insights, and strategic initiatives.

DateReport TitleLinks
06 Nov 2026Paras Healthcare Ltd - 545005 - Announcement under Regulation 30 (LODR)-Investor Presentation

Paras Healthcare - Company Profile

About the company - Business Profile

Paras Healthcare was incorporated on December 21, 1987. It is the fifth largest healthcare provider in terms of bed capacity in North India, Bihar, and Jharkhand. The company has eight hospitals that operate under the “Paras Health” brand, which are spread across five states and one union territory in North India.

Paras Healthcare FAQ

Paras Healthcare today is trading in the green, up by 0.62% at ₹834.95.
Paras Healthcare is currently trading up 0.62% on an intraday basis. In the past week the stock fell 5.36%. Stock has been up 20.48% in the past quarter and rose 20.48% in the past year. You can view this in the share price history/seasonality section.
Paras Healthcare is listed on NSE with the ticker PARASHLTH and on BSE as 545005. It's currently trading on NSE at a share price of ₹834.95 and on BSE with a share price of ₹830.5.
The market cap of Paras Healthcare is ₹9,034.26 Cr. as of Nov 19, 2026.
Paras Healthcare has never announced any dividend since the time of its listing on the BSE/NSE exchanges.
Paras Healthcare has never issued stock splits or bonus shares since the time of its listing on the BSE/NSE exchanges.
Paras Healthcare reported ₹517.35 Cr. in revenue, ₹40.35 Cr. in net profit, and ₹126.63 Cr. in EBITD as of Nov 05, 2026 for Q2 FY26-27.
There are no analyst predictions for stock price target for Paras Healthcare.
The PE ratio of Paras Healthcare is not available as of Nov 20, 2026.
The PB ratio of Paras Healthcare is 20.27 as of Nov 19, 2026.
You can view the latest analyst reports on the Paras Healthcare reports dashboard. Either click on the Reports tab on this page's sub-header or click here to be directed to the dashboard.
You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.